Pacira BioSciences PCRX reported its Q2 earnings results on Wednesday, August 3, 2022.
Here's what investors need to know about the announcement.
Earnings
Pacira BioSciences missed estimated earnings by 42.05%, reporting an EPS of $0.51 versus an estimate of $0.88.
Revenue was up $33.82 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.19 which was followed by a 6.75% drop in the share price the next day.
Here's a look at Pacira BioSciences's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | 0.83 | 0.90 | 0.65 | 0.69 |
EPS Actual | 0.64 | 0.97 | 0.72 | 0.77 |
Revenue Estimate | 159.49M | 155.74M | 130.38M | 128.01M |
Revenue Actual | 157.99M | 159.19M | 127.72M | 135.59M |
To track all earnings releases for Pacira BioSciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.